G Trademark

Trademark Overview

On Monday, June 1, 2015, a trademark application was filed for G with the United States Patent and Trademark Office. The USPTO has given the G trademark a serial number of 86647176. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, March 17, 2026. This trademark is owned by GenScript USA Incorporated. The G trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific, technological and medical research services, namely, the service of providing cloning, protein expression, peptide synthesis and antibody production
g

General Information

Serial Number86647176
Word MarkG
Filing DateMonday, June 1, 2015
Status800 - REGISTERED AND RENEWED
Status DateTuesday, March 17, 2026
Registration Number4881120
Registration DateTuesday, January 5, 2016
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 20, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScientific, technological and medical research services, namely, the service of providing cloning, protein expression, peptide synthesis and antibody production
Description of MarkThe mark consists of A stylized letter "G".

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 8, 2015
Primary Code042
First Use Anywhere DateSunday, July 1, 2007
First Use In Commerce DateSunday, July 1, 2007

Trademark Owner History

Party NameGenScript USA Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854
US
Party NameGenScript USA Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854
US
Party NameGenScript USA Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPiscataway, NJ 08854
US

Trademark Events

Event DateEvent Description
Thursday, June 4, 2015NEW APPLICATION ENTERED
Monday, June 8, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 11, 2015ASSIGNED TO EXAMINER
Thursday, September 17, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 30, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 20, 2015PUBLISHED FOR OPPOSITION
Tuesday, October 20, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 5, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, April 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, April 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 5, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 23, 2021TEAS SECTION 8 & 15 RECEIVED
Monday, July 26, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 26, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, July 26, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, May 30, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 30, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 30, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 30, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Sunday, January 5, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, December 30, 2025TEAS SECTION 8 & 9 RECEIVED
Tuesday, March 17, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 17, 2026REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, March 17, 2026REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, March 17, 2026NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

Related Keywords

expression protein peptide synthesis production antibody cloning providing medical technological